CA2086101C - Produit immunosuppressif - Google Patents

Produit immunosuppressif Download PDF

Info

Publication number: CA2086101C
Authority: CA; Canada
Prior art keywords: milk; allergen; allergens; polypeptide; subject
Prior art date: 1990-07-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA002086101A

Other languages

English (en)

Other versions

CA2086101A1 (fr

Inventor

Lee R. Beck

Ralph J. Stolle

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Stolle Milk Biologics Inc

Original Assignee

Stolle Milk Biologics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-07-05

Filing date

1991-04-26

Publication date

2002-11-19

1991-04-26 Application filed by Stolle Milk Biologics Inc filed Critical Stolle Milk Biologics Inc

1992-01-06 Publication of CA2086101A1 publication Critical patent/CA2086101A1/fr

2002-11-19 Application granted granted Critical

2002-11-19 Publication of CA2086101C publication Critical patent/CA2086101C/fr

2011-04-26 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

235000013336 milk Nutrition 0.000 title claims abstract description 102
239000008267 milk Substances 0.000 title claims abstract description 102
210000004080 milk Anatomy 0.000 title claims abstract description 102
230000006028 immune-suppresssive effect Effects 0.000 title abstract description 15
239000013566 allergen Substances 0.000 claims abstract description 112
206010020751 Hypersensitivity Diseases 0.000 claims abstract description 46
241001465754 Metazoa Species 0.000 claims abstract description 45
238000000034 method Methods 0.000 claims abstract description 43
239000000203 mixture Substances 0.000 claims abstract description 33
208000026935 allergic disease Diseases 0.000 claims description 30
230000007815 allergy Effects 0.000 claims description 26
230000008569 process Effects 0.000 claims description 22
208000024891 symptom Diseases 0.000 claims description 17
241000283690 Bos taurus Species 0.000 claims description 12
235000013305 food Nutrition 0.000 claims description 9
238000004519 manufacturing process Methods 0.000 claims description 5
235000020183 skimmed milk Nutrition 0.000 claims description 4
239000008194 pharmaceutical composition Substances 0.000 claims description 3
235000013351 cheese Nutrition 0.000 claims description 2
239000007788 liquid Substances 0.000 claims description 2
235000013618 yogurt Nutrition 0.000 claims description 2
238000001914 filtration Methods 0.000 claims 4
108090000765 processed proteins & peptides Proteins 0.000 abstract description 64
102000004196 processed proteins & peptides Human genes 0.000 abstract description 61
229920001184 polypeptide Polymers 0.000 abstract description 56
241000894007 species Species 0.000 abstract description 12
238000002347 injection Methods 0.000 abstract description 4
239000007924 injection Substances 0.000 abstract description 4
229960004784 allergens Drugs 0.000 description 29
102000004190 Enzymes Human genes 0.000 description 17
108090000790 Enzymes Proteins 0.000 description 17
229940088598 enzyme Drugs 0.000 description 17
230000000172 allergic effect Effects 0.000 description 13
239000000427 antigen Substances 0.000 description 13
102000036639 antigens Human genes 0.000 description 13
108091007433 antigens Proteins 0.000 description 13
208000010668 atopic eczema Diseases 0.000 description 13
238000000586 desensitisation Methods 0.000 description 11
229920002678 cellulose Polymers 0.000 description 10
239000001913 cellulose Substances 0.000 description 10
230000000694 effects Effects 0.000 description 10
238000002360 preparation method Methods 0.000 description 10
239000000047 product Substances 0.000 description 10
230000004044 response Effects 0.000 description 10
208000030961 allergic reaction Diseases 0.000 description 9
238000006243 chemical reaction Methods 0.000 description 9
239000012634 fragment Substances 0.000 description 9
210000000987 immune system Anatomy 0.000 description 9
235000018102 proteins Nutrition 0.000 description 8
102000004169 proteins and genes Human genes 0.000 description 8
108090000623 proteins and genes Proteins 0.000 description 8
125000000524 functional group Chemical group 0.000 description 7
238000009169 immunotherapy Methods 0.000 description 7
238000012545 processing Methods 0.000 description 7
241000282414 Homo sapiens Species 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
210000004027 cell Anatomy 0.000 description 6
210000002865 immune cell Anatomy 0.000 description 6
-1 sulfopropyl functional group Chemical group 0.000 description 6
229920002307 Dextran Polymers 0.000 description 5
230000008901 benefit Effects 0.000 description 5
239000011159 matrix material Substances 0.000 description 5
230000001681 protective effect Effects 0.000 description 5
244000036975 Ambrosia artemisiifolia Species 0.000 description 4
235000003129 Ambrosia artemisiifolia var elatior Nutrition 0.000 description 4
NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
241000282412 Homo Species 0.000 description 4
210000001744 T-lymphocyte Anatomy 0.000 description 4
230000001939 inductive effect Effects 0.000 description 4
210000002540 macrophage Anatomy 0.000 description 4
230000007246 mechanism Effects 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
239000000243 solution Substances 0.000 description 4
230000001629 suppression Effects 0.000 description 4
CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 3
206010011224 Cough Diseases 0.000 description 3
241000196324 Embryophyta Species 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
241000124008 Mammalia Species 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
229920005654 Sephadex Polymers 0.000 description 3
239000012507 Sephadex™ Substances 0.000 description 3
125000000129 anionic group Chemical group 0.000 description 3
235000003484 annual ragweed Nutrition 0.000 description 3
230000000890 antigenic effect Effects 0.000 description 3
238000013459 approach Methods 0.000 description 3
210000003651 basophil Anatomy 0.000 description 3
235000006263 bur ragweed Nutrition 0.000 description 3
125000002091 cationic group Chemical group 0.000 description 3
235000003488 common ragweed Nutrition 0.000 description 3
230000003247 decreasing effect Effects 0.000 description 3
230000001079 digestive effect Effects 0.000 description 3
238000009472 formulation Methods 0.000 description 3
210000001035 gastrointestinal tract Anatomy 0.000 description 3
230000028993 immune response Effects 0.000 description 3
239000003018 immunosuppressive agent Substances 0.000 description 3
229940126578 oral vaccine Drugs 0.000 description 3
235000009736 ragweed Nutrition 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
206010041232 sneezing Diseases 0.000 description 3
239000000126 substance Substances 0.000 description 3
210000001519 tissue Anatomy 0.000 description 3
239000003981 vehicle Substances 0.000 description 3
244000237956 Amaranthus retroflexus Species 0.000 description 2
235000013479 Amaranthus retroflexus Nutrition 0.000 description 2
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
208000004262 Food Hypersensitivity Diseases 0.000 description 2
206010019233 Headaches Diseases 0.000 description 2
108060003951 Immunoglobulin Proteins 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
108010058846 Ovalbumin Proteins 0.000 description 2
241000209504 Poaceae Species 0.000 description 2
208000003251 Pruritus Diseases 0.000 description 2
208000037656 Respiratory Sounds Diseases 0.000 description 2
208000036071 Rhinorrhea Diseases 0.000 description 2
206010039101 Rhinorrhoea Diseases 0.000 description 2
206010042674 Swelling Diseases 0.000 description 2
206010047924 Wheezing Diseases 0.000 description 2
230000009471 action Effects 0.000 description 2
208000003455 anaphylaxis Diseases 0.000 description 2
230000030741 antigen processing and presentation Effects 0.000 description 2
239000003125 aqueous solvent Substances 0.000 description 2
239000003659 bee venom Substances 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
230000000903 blocking effect Effects 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
235000013365 dairy product Nutrition 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
239000008121 dextrose Substances 0.000 description 2
230000035622 drinking Effects 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
230000002255 enzymatic effect Effects 0.000 description 2
239000003925 fat Substances 0.000 description 2
235000019197 fats Nutrition 0.000 description 2
239000013568 food allergen Substances 0.000 description 2
235000020932 food allergy Nutrition 0.000 description 2
238000005227 gel permeation chromatography Methods 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
231100000869 headache Toxicity 0.000 description 2
210000002443 helper t lymphocyte Anatomy 0.000 description 2
229960001340 histamine Drugs 0.000 description 2
230000000521 hyperimmunizing effect Effects 0.000 description 2
230000000899 immune system response Effects 0.000 description 2
230000003053 immunization Effects 0.000 description 2
238000002649 immunization Methods 0.000 description 2
102000018358 immunoglobulin Human genes 0.000 description 2
230000006872 improvement Effects 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
230000001965 increasing effect Effects 0.000 description 2
230000006698 induction Effects 0.000 description 2
230000003993 interaction Effects 0.000 description 2
238000010255 intramuscular injection Methods 0.000 description 2
239000007927 intramuscular injection Substances 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
230000007803 itching Effects 0.000 description 2
210000004698 lymphocyte Anatomy 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000000474 nursing effect Effects 0.000 description 2
229940092253 ovalbumin Drugs 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
239000000843 powder Substances 0.000 description 2
230000029058 respiratory gaseous exchange Effects 0.000 description 2
QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
238000001228 spectrum Methods 0.000 description 2
239000012730 sustained-release form Substances 0.000 description 2
230000008961 swelling Effects 0.000 description 2
230000009897 systematic effect Effects 0.000 description 2
QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical group C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 2
230000020192 tolerance induction in gut-associated lymphoid tissue Effects 0.000 description 2
229960005486 vaccine Drugs 0.000 description 2
239000002435 venom Substances 0.000 description 2
231100000611 venom Toxicity 0.000 description 2
210000001048 venom Anatomy 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
HVAUUPRFYPCOCA-AREMUKBSSA-N 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C HVAUUPRFYPCOCA-AREMUKBSSA-N 0.000 description 1
BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
208000004998 Abdominal Pain Diseases 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
241000223600 Alternaria Species 0.000 description 1
235000004135 Amaranthus viridis Nutrition 0.000 description 1
206010002198 Anaphylactic reaction Diseases 0.000 description 1
206010002199 Anaphylactic shock Diseases 0.000 description 1
241000269837 Artemisia dubia Species 0.000 description 1
235000003261 Artemisia vulgaris Nutrition 0.000 description 1
206010003402 Arthropod sting Diseases 0.000 description 1
241000228212 Aspergillus Species 0.000 description 1
208000023275 Autoimmune disease Diseases 0.000 description 1
240000004183 Bongardia chrysogonum Species 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
235000014224 Ceanothus americanus Nutrition 0.000 description 1
235000001904 Ceanothus herbaceus Nutrition 0.000 description 1
235000009344 Chenopodium album Nutrition 0.000 description 1
235000005484 Chenopodium berlandieri Nutrition 0.000 description 1
235000009332 Chenopodium rubrum Nutrition 0.000 description 1
241000132536 Cirsium Species 0.000 description 1
102000000503 Collagen Type II Human genes 0.000 description 1
108010041390 Collagen Type II Proteins 0.000 description 1
241000223208 Curvularia Species 0.000 description 1
241000371644 Curvularia ravenelii Species 0.000 description 1
206010011878 Deafness Diseases 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
241000283073 Equus caballus Species 0.000 description 1
208000009386 Experimental Arthritis Diseases 0.000 description 1
206010016946 Food allergy Diseases 0.000 description 1
241000223218 Fusarium Species 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
241000441510 Hormodendrum Species 0.000 description 1
208000001718 Immediate Hypersensitivity Diseases 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
238000006957 Michael reaction Methods 0.000 description 1
241001363490 Monilia Species 0.000 description 1
241000235395 Mucor Species 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
102000006386 Myelin Proteins Human genes 0.000 description 1
108010083674 Myelin Proteins Proteins 0.000 description 1
206010067482 No adverse event Diseases 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
108010003541 Platelet Activating Factor Proteins 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
229920002873 Polyethylenimine Polymers 0.000 description 1
229920001218 Pullulan Polymers 0.000 description 1
241000700159 Rattus Species 0.000 description 1
206010038063 Rectal haemorrhage Diseases 0.000 description 1
241000235527 Rhizopus Species 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
235000000914 Solidago virgaurea Nutrition 0.000 description 1
244000021671 Trianthema portulacastrum Species 0.000 description 1
241000223238 Trichophyton Species 0.000 description 1
241000209140 Triticum Species 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
208000024780 Urticaria Diseases 0.000 description 1
VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
230000002730 additional effect Effects 0.000 description 1
238000005377 adsorption chromatography Methods 0.000 description 1
229940074608 allergen extract Drugs 0.000 description 1
230000002009 allergenic effect Effects 0.000 description 1
230000004075 alteration Effects 0.000 description 1
230000036783 anaphylactic response Effects 0.000 description 1
229940125715 antihistaminic agent Drugs 0.000 description 1
239000000739 antihistaminic agent Substances 0.000 description 1
239000008365 aqueous carrier Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical class CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 1
208000006673 asthma Diseases 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
238000010170 biological method Methods 0.000 description 1
230000031018 biological processes and functions Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
244000309466 calf Species 0.000 description 1
239000002775 capsule Substances 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
238000010924 continuous production Methods 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
239000006071 cream Substances 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
238000011026 diafiltration Methods 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
235000021245 dietary protein Nutrition 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
230000029087 digestion Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
239000000428 dust Substances 0.000 description 1
239000003792 electrolyte Substances 0.000 description 1
230000006862 enzymatic digestion Effects 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
239000000284 extract Substances 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
235000021323 fish oil Nutrition 0.000 description 1
239000012530 fluid Substances 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
230000036541 health Effects 0.000 description 1
239000013628 high molecular weight specie Substances 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
210000003630 histaminocyte Anatomy 0.000 description 1
239000012510 hollow fiber Substances 0.000 description 1
230000036737 immune function Effects 0.000 description 1
230000008076 immune mechanism Effects 0.000 description 1
230000008105 immune reaction Effects 0.000 description 1
230000008629 immune suppression Effects 0.000 description 1
230000006058 immune tolerance Effects 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
229940088592 immunologic factor Drugs 0.000 description 1
239000000367 immunologic factor Substances 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
230000006651 lactation Effects 0.000 description 1
239000008101 lactose Substances 0.000 description 1
244000142813 lacy ambrosia Species 0.000 description 1
239000006193 liquid solution Substances 0.000 description 1
210000005075 mammary gland Anatomy 0.000 description 1
239000000463 material Substances 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
102000035118 modified proteins Human genes 0.000 description 1
108091005573 modified proteins Proteins 0.000 description 1
210000004877 mucosa Anatomy 0.000 description 1
210000005012 myelin Anatomy 0.000 description 1
210000000440 neutrophil Anatomy 0.000 description 1
239000000346 nonvolatile oil Substances 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
150000002895 organic esters Chemical class 0.000 description 1
230000001151 other effect Effects 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
231100000614 poison Toxicity 0.000 description 1
239000002574 poison Substances 0.000 description 1
239000013573 pollen allergen Substances 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
235000019423 pullulan Nutrition 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
230000011514 reflex Effects 0.000 description 1
210000001533 respiratory mucosa Anatomy 0.000 description 1
230000004043 responsiveness Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
235000002020 sage Nutrition 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
230000028327 secretion Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
230000001235 sensitizing effect Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
229940076279 serotonin Drugs 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
244000013992 southern ragweed Species 0.000 description 1
235000006245 southern ragweed Nutrition 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
238000003860 storage Methods 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
125000000542 sulfonic acid group Chemical group 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
239000003826 tablet Substances 0.000 description 1
125000001302 tertiary amino group Chemical group 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Immunology (AREA)
Animal Behavior & Ethology (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Developmental Biology & Embryology (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Dairy Products (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

CA002086101A 1990-07-05 1991-04-26 Produit immunosuppressif Expired - Fee Related CA2086101C (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US54841990A	1990-07-05	1990-07-05
US548,419		1990-07-05
PCT/US1991/002923 WO1992000756A1 (fr)	1990-07-05	1991-04-26	Produit immunosuppresseur

Publications (2)

Publication Number	Publication Date
CA2086101A1 CA2086101A1 (fr)	1992-01-06
CA2086101C true CA2086101C (fr)	2002-11-19

Family

ID=24188777

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002086101A Expired - Fee Related CA2086101C (fr)	1990-07-05	1991-04-26	Produit immunosuppressif

Country Status (6)

Country	Link
EP (1)	EP0646017A1 (fr)
JP (1)	JP3054194B2 (fr)
AU (1)	AU648800B2 (fr)
CA (1)	CA2086101C (fr)
NZ (2)	NZ238117A (fr)
WO (1)	WO1992000756A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPP494798A0 (en)	1998-07-29	1998-08-20	Pacific Biolink Pty Limited	Protective protein formulation
GB0002386D0 (en) *	2000-02-02	2000-03-22	Novartis Nutrition Ag	Therapeutic composition
US7060687B2 (en)	2001-02-07	2006-06-13	Genmont Biotechnology Co.	Live vaccines for allergy treatment
US20020197268A1 (en) *	2001-06-08	2002-12-26	Hsu Ching-Hsaing	Allergen-containing milk for allergy treatment
US6770280B1 (en)	2001-11-15	2004-08-03	Humanetics Corporation	Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
CA2684392A1 (fr) *	2007-04-16	2008-10-23	Friesland Brands B.V.	Anticorps specifiques a un antigene derive du lait, procedes de fabrication et utilisation de ceux-ci
NL1033696C2 (nl) *	2007-04-16	2008-10-20	Friesland Brands Bv	Aan melk ontleende antigeen-specifieke antilichamen, werkwijzen voor het bereiden en gebruik ervan.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3128230A (en) *	1961-04-04	1964-04-07	Sunbury Milk Products Co	Milk having antibodies therein and process for producing same
US3376198A (en) *	1965-07-21	1968-04-02	Collins Products Inc	Method of producing antibodies in milk
US4732757A (en) *	1978-02-06	1988-03-22	Stolle Research And Development Corporation	Prevention and treatment of rheumatoid arthritis
US4284623A (en) *	1979-11-09	1981-08-18	Beck Lee R	Method of treating inflammation using bovine milk
US4636384A (en) *	1982-06-03	1987-01-13	Stolle Research & Development Corporation	Method for treating disorders of the vascular and pulmonary systems
US5242691A (en) *	1982-06-03	1993-09-07	Stolle Research & Development Corporation	Anti-inflammatory factor, method of isolation, and use
US4879110A (en) *	1983-10-27	1989-11-07	Stolle Research And Development Corporation	Antihypertensive hyperimmune milk, production, composition, and use
USRE33403E (en) *	1982-06-03	1990-10-23	Stolle Research & Development Corporation	Method for treating disorders of the vascular and pulmonary systems
US4956349A (en) *	1983-10-27	1990-09-11	Stolle Research & Development Corporation	Anti-inflammatory factor, method of isolation, and use
AU590711B2 (en) *	1982-10-13	1989-11-16	Biowhittaker, Inc.	Stable allergenic extracts and methods

1991
- 1991-04-26 EP EP91909691A patent/EP0646017A1/fr not_active Withdrawn
- 1991-04-26 CA CA002086101A patent/CA2086101C/fr not_active Expired - Fee Related
- 1991-04-26 WO PCT/US1991/002923 patent/WO1992000756A1/fr not_active Ceased
- 1991-04-26 JP JP3509229A patent/JP3054194B2/ja not_active Expired - Fee Related
- 1991-04-26 AU AU78916/91A patent/AU648800B2/en not_active Ceased
- 1991-05-10 NZ NZ238117A patent/NZ238117A/en unknown
- 1991-05-10 NZ NZ505179A patent/NZ505179A/en active IP Right Revival

Also Published As

Publication number	Publication date
AU648800B2 (en)	1994-05-05
AU7891691A (en)	1992-02-04
NZ505179A (en)	2002-06-28
EP0646017A1 (fr)	1995-04-05
WO1992000756A1 (fr)	1992-01-23
JP3054194B2 (ja)	2000-06-19
JPH05508397A (ja)	1993-11-25
CA2086101A1 (fr)	1992-01-06
EP0646017A4 (fr)	1993-07-12
NZ238117A (en)	1996-01-26

Legal Events

Date	Code	Title	Description
1998-03-27	EEER	Examination request
2008-04-28	MKLA	Lapsed

Publication	Publication Date	Title
US5645851A (en)	1997-07-08	Product for alleviating the symptons of arthritis in mammals
EP0498854A1 (fr)	1992-08-19	Serums antivenimeux et leurs procedes de fabrication
US5529786A (en)	1996-06-25	Process and product for treatment of rheumatoid arthritis
FI98269C (fi)	1997-05-26	Menetelmä olennaisesti puhtaan tulehdusta estävän tekijän eristämiseksi maidosta
US5863561A (en)	1999-01-26	Immune suppressive product
CA2086101C (fr)	2002-11-19	Produit immunosuppressif
US5637321A (en)	1997-06-10	Method for preparing animal tissue for use in alleviating the symptoms of arthritis in mammals
JP4554728B2 (ja)	2010-09-29	移植片拒絶反応またはアレルギーまたは自己免疫反応と関連した病状を治療するための医薬または食品組成物
JP2003521524A (ja)	2003-07-15	乳中のアレルゲンの経口送達
DE69737191T2 (de)	2007-11-08	Entzündungshemmende Zusammensetzung aus Ei, Verfahren zur Isolierung und Verwendung
WO1998047529A1 (fr)	1998-10-29	Combinaisons d'antigene et de composant de liaison propre aux muqueuses, utilisees pour l'induction d'une tolerance immunitaire specifique
JPH03505866A (ja)	1991-12-19	抗高血圧過免疫ミルク、製法、組成物及び用途
US6054124A (en)	2000-04-25	Immune suppressive product
CA2317813A1 (fr)	1999-07-22	Composition et methode de traitement et de prevention de l'arthrite et/ou de maladies auto-immunes
CN103087194B (zh)	2014-05-14	一种抗血循型蛇毒鸡卵黄抗体及其应用
UA128640C2 (uk)	2024-09-11	Спосіб одержання очищенного екстракту алергену
JPH07138187A (ja)	1995-05-30	経口免疫寛容原、経口慢性関節リウマチ治療剤及び機能性食品
JPH04300839A (ja)	1992-10-23	脂質分解酵素阻害剤
Tarigan et al.	2016	Effectivity of immunoglobulin Y anti lipase as a pancreatic lipase inhibitor for prevention of obesity
JPH09315998A (ja)	1997-12-09	スギ花粉症の予防および／または治療剤
Alam et al.	1988	Production and properties of histamine-releasing factor of guinea pigs.
US20250249091A1 (en)	2025-08-07	TREATMENT OF ALLERGY WITH DIMERIC IgA or SECRETORY IgA ANTIGEN IMMUNE COMPLEXES
US20220079999A1 (en)	2022-03-17	Antivenom compositions and uses thereof
EP0215081A1 (fr)	1987-03-25	Preparations d'immunoglobulines presentant des titres eleves en anticorps bloquants
CN1557836A (zh)	2004-12-29	免疫抑制多肽的制备及应用